Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of N-acetyl Cysteine as an Adjuvant Therapy on Symptoms and Progression of Parkinson's Disease

NCT07093944 is registered in ClinicalTrials.gov with Kurdistan University of Medical Sciences as lead sponsor.

NCT NCT07093944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07093944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of N-acetyl Cysteine as an Adjuvant Therapy on Symptoms and Progression of Parkinson's Disease
Lead sponsor
Kurdistan University of Medical Sciences
Phase
Phase 2
Overall status
Completed
Start date
April 9, 2018
Completion date
December 22, 2021
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)